Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo

Stem Cells

Volumn 29, Issue 2, 2011, Pages 206-216

  Bilousova, Ganna ^a,b   Jun, Du Hyun ^a   King, Karen B ^b   De Langhe, Stijn ^c   Chick, Wallace S ^a   Torchia, Enrique C ^a,b   Chow, Kelsey S ^a   Klemm, Dwight J ^a   Roop, Dennis R ^a,b   Majka, Susan M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Differentiation; iPS cells; Mesenchymal lineages; Osteoblasts

Indexed keywords

BONE SIALOPROTEIN; COMPLEMENTARY DNA; OSTEOCALCIN; RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE; CALCIFICATION; CARTILAGE; CELL DIFFERENTIATION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; TERATOMA;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INDUCED PLURIPOTENT STEM CELLS; INTEGRIN-BINDING SIALOPROTEIN; MICE; MICE, INBRED ICR; MICE, NUDE; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHENOTYPE; TISSUE SCAFFOLDS;

IPS; MURINAE; MUS;

EID: 79952182080     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.566     Document Type: Article

References (47)

1. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872. (Pubitemid 350138099)
2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
3. Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-324.
4. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49. (Pubitemid 46865811)
5. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
6. Vogel G. Reprogrammed cells come up short, for now. Science 2010; 327:1191.
7. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187-208.
8. Arrington ED, Smith WJ, Chambers HG et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996;329:300-309.
9. Kainer MA, Linden JV, Whaley DN, et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004;350:2564-2571. (Pubitemid 38758543)
10. Granero-Molto F, Weis JA, Longobardi L et al. Role of mesenchymal stem cells in regenerative medicine: Application to bone and cartilage repair. Exp Opin Biol Ther 2008;8:255-268. (Pubitemid 351428415)
11. Lian Q, Zhang Y, Zhang J, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010;121:1113-1123.
12. Stenderup K, Justesen J, Clausen C et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926. (Pubitemid 37543568)
13. Marion RM, Strati K, Li H, et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. 2009;4:141-154.
14. Agarwal S, Loh Y-H, McLoughlin EM, et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010;464:292-296.
15. Li F, Bronson S, Niyibizi C. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. J Cell Biochem 2010;109:643-652.
16. Mizuno Y, Chang H, Umeda K, et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J 2010;24:2245-2253.
17. Tashiro K, Inamura M, Kawabata K, et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009;27:1802-1811.
18. Taura D, Noguchi M, Sone M, et al. Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of human embryonic stem cells. FEBS Lett 2009;583:1029-1033.
19. Taura D, Sone M, Homma K, et al. Induction and isolation of vascular cells from human induced pluripotent stem cells - Brief report. Arterioscler Thromb Vasc Biol 2009;29:1100-1103.
20. Huangfu D, Osafune K, Maehr R, et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 2008;26:1269-1275.
21. Kawaguchi J. Generation of osteoblasts and chondrocytes from embryonic stem cells. Methods Mol Biol 2006;330:135-148.
22. Kawaguchi J, Mee PJ, Smith AG. Osteogenic and chondrogenic differentiation of embryonic stem cells in response to specific growth factors. Stem Cells 2005;36:758-769. (Pubitemid 40616010)
23. Dani C, Smith AG, Dessolin S et al. Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 1997;110:1279-1285. (Pubitemid 27273698)
24. Wiper-Bergeron N, St-Louis C, Lee JM. CCAAT/enhancer binding protein {beta} abrogates retinoic acid-induced osteoblast differentiation via repression of Runx2 transcription. Mol Endocrinol 2007;21:2124-2135. (Pubitemid 47347377)
25. van Haaften T, Byrne R, Bonnet S, et al. Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009;180:1131-1142.
26. Yuspa SH, Kilkenny AE, Steinert PM, Roop DR. Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol 1989;109:1207-1217. (Pubitemid 19220102)
27. Martin J, Helm K, Ruegg P, et al. Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 2008;10:140-151.
28. Maes C, Carmeliet G. VEGF in development: Vascular and nonvascular roles of VEGF in bone development (Madame Curie Bioscience Database). 2008, Bookshelf ID: NBK6134.
29. Bin NH, Jin AH, Lee W-J et al. The molecular signature of in vitro senescence in human mesenchymal stem cells. Genes Genomics 2010;32:87-93.
30. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 2008;314:1937-1944.
31. Zavazava N. Embryonic stem cells and potency to induce transplantation tolerance. Expert Opin Biol Ther 2003;3:5-13. (Pubitemid 36193647)
32. Koch CA, Geraldes P, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells 2008;26:89-98.
33. Grinnemo KH, Kumagai-Braesch M, Månsson-Broberg A, et al. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 2006;13:712-724. (Pubitemid 44760896)
34. Swijnenburg RJ, Tanaka M, Vogel H, et al. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 2005;112(9 suppl):I166-I172. (Pubitemid 41266669)
35. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317. (Pubitemid 47080336)
36. Lian Q, Lye E, Suan Yeo K, et al. Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells 2007;25:425-436.
37. Barberi T, Willis LM, Socci ND et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. Plos Med 2005;2:e161.
38. James MJ, Järvinen E, Wang XP et al. Different roles of Runx2 during early neural crest-derived bone and tooth development. J Bone Miner Res 2006;21:1034-1044. (Pubitemid 43962832)
39. Enomoto H, Furuichi T, Zanma A, et al. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J Cell Sci 2004;117:417-425. (Pubitemid 38181203)
40. Xiao G, Wang D, Benson MD et al. Role of the Œ62-Integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998;273:32988-32994.
41. Müller A, Mehrkens A, Schäfer DJ et al. Towards an intraoperative engineering of osteogenic and vasculogenic grafts from the stromal vascular fraction of human adipose tissue. Eur Cell Mater 2010;3:127-135.
42. Tremoleda J, Forsyth NR, Khan NS et al. Bone tissue formation from human embryonic stem cells in vivo. Cloning Stem Cells 2008;10:119-132.
43. Duan X, Tu Q, Zhang J, et al. Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. J Cell Physiol 2010;226:150-157.
44. Naujoks C, Langenbach F, Berr K et al. Biocompatibility of osteogenic predifferentiated human cord blood stem cells with biomaterials and the influence of the biomaterial on the process of differentiation. J Biomater Appl 2010.
45. Smith LA, Liu X, Hu J et al. The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding. Biomaterials 2010;31:5526-5535.
46. Pelttari K, Wixmerten A, Martin I. Do we really need cartilage tissue engineering? Swiss Med Wkly 2009;139:602-609.
47. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human iPS cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010;28:1728-1740.